BRCA1 and cancer: BRCA1-deficient cancers including breast, ovary and other cancers exhibit the SBS3 signature characterized by the uniform distribution of all base substitution types, the ID6 signature by small 11–50 bp indels with short microhomology (MH) at junctions, small ~10 kb MH-mediated TDs, and unbalanced translocations1–7.